As of 2025-07-04, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.12 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of BetterLife Pharma Inc is -235.38%.
Based on its market price of 0.09 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 235.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.12 - -0.12 | -0.12 | -235.38% |
| DDM - Stable | (0.25) - (3.68) | (1.96) | -2281.6% |
| DDM - Multi | (0.78) - (9.41) | (1.48) | -1739.3% |
| Market Cap (mil) | 13.00 |
| Beta | 0.11 |
| Outstanding shares (mil) | 144.46 |
| Enterprise Value (mil) | 13.91 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.69% |
| Cost of Debt | 5.00% |
| WACC | 7.45% |